COMMUNIQUÉS West-GlobeNewswire

-
Dynavax Announces Publication of Two Papers in Leading Oncology Journal Highlighting Data From Clinical Studies of Its TLR9 Agonist, SD-101
28/08/2018 -
Bhang Accelerates Growth with New Headquarters in Miami
28/08/2018 -
G1 Therapeutics to Present at H.C. Wainwright Investment Conference on September 5, 2018
28/08/2018 -
Financial Calendar 2018/19
28/08/2018 -
Transactions in relation to share buyback program
28/08/2018 -
Aino Health AB (publ): Aino Health signs agreement with Sjuksyrra AB
28/08/2018 -
GENFIT: Major Milestone achieved with full recruitment of the Phase 2 trial evaluating elafibranor in PBC
28/08/2018 -
GENFIT : étape importante franchie avec la fin du recrutement des patients de l'essai de Phase 2 évaluant elafibranor dans la PBC
28/08/2018 -
GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology
28/08/2018 -
ObsEva SA to Participate in September Investor Conferences
28/08/2018 -
MDxHealth (R): SelectMDx Cost-effective in Four European Countries
28/08/2018 -
MDxHealth (R) :
28/08/2018 -
MDxHealth (R): SelectMDx Cost-effective in Four European Countries
28/08/2018 -
MDxHealth (R) : SelectMDx : rapport coût-effectivité positif dans quatre pays européens
28/08/2018 -
Biocartis Group NV: Biocartis Obtains Exclusive Worldwide License Rights for EGFR Ectodomain Mutations Determining Response to Targeted Colorectal Cancer Therapy
28/08/2018 -
Kiadis Pharma to attend upcoming investor conferences in September 2018
28/08/2018 -
Orphazyme announces Interim Report First Half 2018
28/08/2018 -
Wright Medical Group N.V. Announces Pricing of Public Offering of Ordinary Shares
28/08/2018 -
EB Research Partnership and EB Research Foundation Join Forces to Advance Breakthroughs in Epidermolysis Bullosa Research
28/08/2018
Pages